Lung Cancer Research Foundation
Lung Cancer Research Foundation shows consistent revenue growth and asset accumulation with no reported officer compensation.
EIN: 141935776 · Philadelphia, PA · NTEE: H30 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $7.8M |
| Total Expenses | $6.4M |
| Program Spending | 80% |
| CEO/Top Officer Pay | $6 |
| Net Assets | $3.6M |
| Transparency Score | 85/100 |
Is Lung Cancer Research Foundation Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Lung Cancer Research Foundation directs 80% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Lung Cancer Research Foundation
Lung Cancer Research Foundation (EIN: 141935776) is a nonprofit organization based in Philadelphia, PA, classified under NTEE code H30. The organization reported total revenue of $7.8M and total assets of $7.5M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Lung Cancer Research Foundation's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Lung Cancer Research Foundation is a mid-size nonprofit that has been operating for 21 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 16.2%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $6.4M |
| Total Expenses | $6.4M |
| Surplus / Deficit | $-36,274 |
| Total Assets | $6.9M |
| Total Liabilities | $3.3M |
| Net Assets | $3.6M |
| Operating Margin | -0.6% |
| Debt-to-Asset Ratio | 47.7% |
| Months of Reserves | 13.0 months |
Financial Health Grade: B
In 2023, Lung Cancer Research Foundation reported a deficit of $36K with expenses exceeding revenue, holds 13.0 months of operating reserves (strong position), has a debt-to-asset ratio of 47.7% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), Lung Cancer Research Foundation's revenue has grown at a compound annual growth rate (CAGR) of 16.2%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -3.3% | -2.0% | +25.0% |
| 2022 | +7.3% | +22.8% | -3.2% |
| 2021 | +15.8% | +6.2% | +25.2% |
| 2020 | -0.5% | -9.2% | +15.4% |
| 2019 | -3.4% | -12.5% | -20.9% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2005 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Lung Cancer Research Foundation with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 80%
- fundraising: 10%
According to IRS 990 filings, Lung Cancer Research Foundation allocates its expenses as follows: admin: 10%, programs: 80%, fundraising: 10%. With 80% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $36K, with expenses exceeding revenue.
- Debt-to-asset ratio: 47.7%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, which is highly unusual for an organization of its size with revenues reaching over $6 million. This suggests either a fully volunteer executive leadership or that executive compensation is categorized differently within the expense structure, requiring deeper scrutiny for full transparency.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Lung Cancer Research Foundation's IRS 990 filings:
- Unusually low (0%) reported officer compensation across all filings, which may obscure actual leadership costs.
- Liabilities have increased significantly from $36,983 in 2014 to $3,310,501 in 2023, warranting further investigation into their nature.
Strengths
The following positive indicators were identified for Lung Cancer Research Foundation:
- Consistent revenue growth, from $1.6M in 2014 to $6.3M in 2023, demonstrating strong fundraising capabilities.
- Significant asset accumulation, growing from $1.2M in 2014 to $6.9M in 2023, indicating financial stability.
- Generally stable financial operations with expenses closely managed against revenues in recent years (e.g., 2023 expenses $6,423,446 vs. revenue $6,387,172).
Frequently Asked Questions about Lung Cancer Research Foundation
Is Lung Cancer Research Foundation a legitimate charity?
Lung Cancer Research Foundation (EIN: 141935776) is a registered tax-exempt nonprofit based in Pennsylvania. Our AI analysis gives it a Mission Score of 85/100. It has 13 years of IRS 990 filings on record. Total revenue: $7.8M. 2 red flags identified. 3 strengths noted. Financial health grade: B.
How does Lung Cancer Research Foundation spend its money?
Lung Cancer Research Foundation directs 80% of its spending to programs and services. Fundraising costs 10%. This exceeds the 65% industry benchmark.
Are donations to Lung Cancer Research Foundation tax-deductible?
Lung Cancer Research Foundation is registered as a tax-exempt nonprofit (EIN: 141935776). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Lung Cancer Research Foundation CEO make?
Lung Cancer Research Foundation's highest-compensated officer earns $6 annually. The organization reported $7.8M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Lung Cancer Research Foundation's spending goes to programs?
Lung Cancer Research Foundation directs 80% to programs, 10% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Lung Cancer Research Foundation compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), Lung Cancer Research Foundation is above average for NTEE category H30 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Lung Cancer Research Foundation located?
Lung Cancer Research Foundation is headquartered in Philadelphia, Pennsylvania and files with the IRS under EIN 141935776. It is classified under NTEE code H30.
How many years of IRS 990 filings does Lung Cancer Research Foundation have?
Lung Cancer Research Foundation has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $7.8M in total revenue.
Is Lung Cancer Research Foundation a good charity?
Based on its consistent revenue growth, increasing assets from $1.2M in 2014 to $6.9M in 2023, and the absence of reported officer compensation, the organization appears to be financially healthy and focused on its mission. However, a detailed breakdown of program vs. administrative spending would provide a more complete picture of its efficiency.
How has the organization's financial health changed over time?
The organization has demonstrated strong financial growth, with revenues increasing from $1,661,221 in 2014 to $6,387,172 in 2023, and assets growing from $1,232,622 to $6,946,397 over the same period. This indicates a positive trend in financial health and sustainability.
What is the significance of 0% officer compensation?
The consistent reporting of 0% officer compensation across all filings is highly unusual for an organization with annual revenues exceeding $6 million. It could indicate a volunteer-led executive team, or that executive compensation is embedded within other expense categories, which would require further investigation for complete transparency regarding leadership costs.
Filing History
IRS 990 filing history for Lung Cancer Research Foundation showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Lung Cancer Research Foundation's revenue has grown by 507.6%, moving from $1.1M to $6.4M. Total assets increased by 232.4% over the same period, from $2.1M to $6.9M. Total functional expenses rose by 285.8%, from $1.7M to $6.4M. In its most recent filing year (2023), Lung Cancer Research Foundation reported a deficit of $36K, with expenses exceeding revenue. The organization holds $3.3M in liabilities against $6.9M in assets (debt-to-asset ratio: 47.7%), resulting in net assets of $3.6M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $6.4M | $6.4M | $6.9M | $3.3M | — | View 990 |
| 2022 | $6.6M | $6.6M | $5.6M | $2.0M | — | View 990 |
| 2021 | $6.2M | $5.3M | $5.7M | $2.2M | — | View 990 |
| 2020 | $5.3M | $5.0M | $4.6M | $1.9M | — | View 990 |
| 2019 | $5.3M | $5.5M | $4.0M | $1.6M | — | View 990 |
| 2018 | $5.5M | $6.3M | $5.0M | $2.4M | — | View 990 |
| 2017 | $4.6M | $4.6M | $5.4M | $2.0M | — | — |
| 2016 | $3.7M | $4.2M | $3.3M | $1.1M | — | View 990 |
| 2015 | $3.7M | $3.6M | $3.5M | $792K | — | View 990 |
| 2014 | $1.7M | $1.8M | $1.2M | $37K | — | View 990 |
| 2013 | $1.3M | $1.5M | $1.3M | $33K | — | View 990 |
| 2012 | $1.1M | $1.6M | $1.5M | $38K | — | View 990 |
| 2011 | $1.1M | $1.7M | $2.1M | $84K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $6.4M, expenses of $6.4M, and assets of $6.9M (revenue -3.3% year-over-year).
- 2022: Revenue of $6.6M, expenses of $6.6M, and assets of $5.6M (revenue +7.3% year-over-year).
- 2021: Revenue of $6.2M, expenses of $5.3M, and assets of $5.7M (revenue +15.8% year-over-year).
- 2020: Revenue of $5.3M, expenses of $5.0M, and assets of $4.6M (revenue -0.5% year-over-year).
- 2019: Revenue of $5.3M, expenses of $5.5M, and assets of $4.0M (revenue -3.4% year-over-year).
- 2018: Revenue of $5.5M, expenses of $6.3M, and assets of $5.0M (revenue +19.2% year-over-year).
- 2017: Revenue of $4.6M, expenses of $4.6M, and assets of $5.4M (revenue +25.3% year-over-year).
- 2016: Revenue of $3.7M, expenses of $4.2M, and assets of $3.3M (revenue -1.1% year-over-year).
- 2015: Revenue of $3.7M, expenses of $3.6M, and assets of $3.5M (revenue +125.2% year-over-year).
- 2014: Revenue of $1.7M, expenses of $1.8M, and assets of $1.2M (revenue +24.3% year-over-year).
- 2013: Revenue of $1.3M, expenses of $1.5M, and assets of $1.3M (revenue +23.6% year-over-year).
- 2012: Revenue of $1.1M, expenses of $1.6M, and assets of $1.5M (revenue +2.9% year-over-year).
- 2011: Revenue of $1.1M, expenses of $1.7M, and assets of $2.1M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Lung Cancer Research Foundation:
Data Sources and Methodology
This transparency report for Lung Cancer Research Foundation is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.